PRNews

Alliance Group Launches CGL Alliance and Secures Insurance Intermediary License in Germany

Cision | Fri, Oct 18 2024 07:13 PM AEDT

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz

HAMBURG, Germany, Oct. 16, 2024 /PRNewswire/ -- Alliance Group International Ltd is proud to announce the launch of its latest subsidiary, CGL Alliance GmbH, which has successfully secured its insurance intermediary license from the Hamburg Chamber of Commerce (Handelskammer Hamburg). This milestone marks a significant step in Alliance Group's expansion within the European insurance market.

CGL Alliance GmbH, as a wholly owned subsidiary of Alliance Group International Ltd, will act as a licensed insurance intermediary, offering comprehensive insurance solutions across Europe. This license enables the company to mediate insurance products in compliance with local regulations, further strengthening Alliance Group's global presence and commitment to providing high-quality financial and insurance services.

The supervisory authority for CGL Alliance GmbH's activities is the Hamburg Chamber of Commerce, located at Adolphsplatz 1, 20457 Hamburg. This regulatory oversight ensures that CGL Alliance GmbH operates within the legal framework of Germany, guaranteeing clients the highest standards of professionalism and service.

Alliance Group Head of Legal, Licensing & Compliance, Richard Blackburn commented:

"The launch of CGL Alliance GmbH is a crucial development in our strategy to expand our services in Europe. With this new license, we are well-positioned to offer tailored insurance solutions to meet the growing needs of clients across the continent. We are excited about the opportunities ahead and the continued growth of the Alliance Group family."*

CGL Alliance GmbH will initially focus on providing specialized insurance intermediation services, with plans to broaden its offerings as the European market evolves.

Visit www.welcometoalliance.com for more information

PRNews

LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing

Phase 1 trial of LM-299, an anti-PD-1/VEGF BsAb, initiated in China for advanced solid tumors following promising preclinical results demonstrating ...

Cision | Fri, Oct 18 2024 09:00 PM AEDT

Read More
PRNews

Race to the Top: Bybit Adds $1 Million to WSOT 2024 Prize Pool - Final Days to Register!

DUBAI, UAE, Oct. 18, 2024 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, makes another statement in rewarding ...

Cision | Fri, Oct 18 2024 09:00 PM AEDT

Read More
PRNews

Singapore Welcomes the Iconic Amerigo Vespucci for Its Historic First Visit This October

Amerigo Vespucci and the Villaggio Italia will be docking in Singapore from October at the Marina Bay Cruise Centre where ...

Cision | Fri, Oct 18 2024 09:00 PM AEDT

Read More
PRNews

HGS launches its AI Hub in Manila to boost digital experience for clients

MANILA, Philippines and SYDNEY, Oct. 18, 2024 /PRNewswire/ -- Hinduja Global Solutions (HGS) (listed on BSE & NSE), a leading provider of ...

Cision | Fri, Oct 18 2024 08:47 PM AEDT

Read More
Stock Market

Netflix shares jump premarket after streaming giant unveils upbeat guidance

Investing.com -- Netflix (NASDAQ:NFLX) has reported better-than-anticipated quarterly income, in a sign of the streaming giant's push to ...

Investing | Fri, Oct 18 2024 08:45 PM AEDT

Read More